首页> 中国专利> 口服药物组合物和其用于制备治疗或预防疾病的药物的用途

口服药物组合物和其用于制备治疗或预防疾病的药物的用途

页面导航

摘要
著录项
相似文献

摘要

本发明涉及一种组合物，包括：含有衍生自植物的精油的精油部分和具有脂肪酸的载体油部分，其中植物的属选自由母菊属、柑橘属、牛至属、迷迭香属、刺柏属和薰衣草属组成的组。本发明还涉及将口服药物组合物用于制备治疗或预防疾病的药物的用途。本发明还涉及一种膳食补充剂组合物。

著录项

公开/公告号CN107320552B

专利类型发明专利
公开/公告日2022-08-09

原文格式PDF
申请/专利权人赖冬妮;
展开▼

申请/专利号CN201710217749.5
发明设计人赖冬妮;
展开▼

申请日2017-04-05
分类号A61K36/752(2006.01);A61P1/16(2006.01);A61P9/10(2006.01);A61P7/02(2006.01);A61P35/00(2006.01);A23L33/105(2016.01);A23L33/12(2016.01);
代理机构北京润平知识产权代理有限公司 11283;北京润平知识产权代理有限公司 11283;
代理人严政;刘依云
地址中国香港湾仔骆克道93-107号
入库时间 2022-09-06 00:40:17

相似文献

专利
中文文献
外文文献

1. 二苯氧基烷基胺衍生物和芳氧基烷基胺衍生物、药物组合物、所述药物组合物用于治疗、预防或抑制慢性肺炎性疾病的用途和用于治疗或预防所述疾病的方法 [P] . 中国专利： CN105517991A . 2016-04-20
2. 口服药物组合物和其用于制备治疗或预防疾病的药物的用途 [P] . 中国专利： CN107320552B . 2022.08.09
3. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
4. Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals [P] . BR0102185A . 2003-02-18

机译：包含catuama提取物作为抗氧化剂或脑血管舒张剂的产品的用途，包含该产品的药物组合物用于预防或治疗由自由基的不当存在引起的血管疾病和病症，预防或治疗脑血管疾病和病症的方法由于使用所述产品不当按压自由基而导致的疾病，以及所述产品在制备药物组合物中的用途，所述药物组合物用于预防或治疗血管疾病和由自由基的不当存在引起的疾病
5. formulation, drug dosage form for oral transmucosal administration, transmucosal drug delivery system, method of treatment and prophylaxis of a disease or disorder, method of treatment, formulation, method for treatment or prevention of head and neck squamous cell carcinoma (hnscc), method for chemoprevention of an oral cancer or precancerous condition, method for increasing the concentration of a retinide composition, method of treatment and prophylaxis of a disease or condition, ratification method of a subject presenting a symptomatic medical condition , method of treating an oral cancer or precancerous condition in a patient, method for making an oral drug delivery system, method for increasing the release and permeation of a retinide composition. [P] . BR112013011942A2 . 2016-11-01

机译：制剂，经粘膜口服给药的药物剂型，经粘膜给药系统，疾病或病症的治疗和预防方法，治疗方法，制剂，头颈鳞状细胞癌（hnscc）的治疗或预防方法，口腔癌或癌前状态的化学预防，增加视黄素组合物的浓度的方法，疾病或病状的治疗和预防方法，表现出症状性医学病状的受试者的批准方法，口腔癌或癌前状态的治疗方法在患者中，用于制备口服药物递送系统的方法，用于增加视黄素组合物的释放和渗透的方法。